リフアンピシンRifampicinによる猩紅熱の治療

仁平 誠, 冨沢 功, 秋葉 亨

doi:10.11150/kansenshogakuzasshi1970.46.201

リフアンピシンRifampicinによる猩紅熱の治療

DOI Web Site

仁平誠

市立札幌病院隔離病舎
冨沢功

市立札幌病院隔離病舎
秋葉亨

市立札幌病院隔離病舎

書誌事項

タイトル別名

Rifampicin Therapy of Scarlet Fever
リファンピシン Rifampicinによる猩紅熱の治療
リファンピシン Rifampicin ニヨルショウコウネツノチリョウ

この論文をさがす

説明

Rifampicin was tried in the treatment of scarlet fever and effects to the eradication of pharyngeal streptococcus haemolyticus and fever were observed, giving the dose of 20 mg/Kg Rifampicin in 57 and 30 mg/Kg in 10 child patients for 7 days. The results were evaluated as follows: In the group given 20 mg/Kg Rifampicin, the effects were classified as: 27 excellent, 9 good, 16 fair, and 5 ineffective. In the group given 30 mg/Kg Rifampicin, 5 excellent, 2 good, and 3 fair. From above results, Rifampicin can be registered as first choice drug for scarlet fever as effective as erythromycin. Besides, it should be a great advantage in the use that it needs only once a day dose. Two cases of exanthema and transient hematuria, respectively, were encountered as side effects.